Alira Health as Strategic Advisor to Benvic in Acquisition Luc & Bel

Drawing on CDMO and biomedical expertise, Alira Health helped AGC Biologics become one of the few companies offering both plasmid production and cell and gene therapy services.

Published on:
November 29, 2020

We are proud to announce our role as strategic advisor to Benvic in the acquisition of Luc & Bel.

Benvic is a French group leader in the production of highly innovative PVC-based thermoplastic solutions and ecological biopolymers.

For more information, please contact Gabriele Brambilla.

To read the full press release

Click here

Aenean ut neque vehicula, iaculis odio ut, porta risus. In gravida libero faucibus ex vulputate pharetra. Donec sed sapien odio. Donec vel pellentesque eros. Aliquam erat volutpat. Suspendisse luctus massa accumsan, egestas lacus ac, aliquam libero. Praesent mollis magna vel mi fermentum pulvinar. Fusce quis ultricies sapien, eu suscipit ligula. Duis ut enim ac felis scelerisque sodales. Quisque a elit ac mi cursus posuere vitae sed augue. Nunc varius a ex eget posuere. Nullam fringilla aliquet diam. Maecenas mattis ac massa id fermentum. Proin convallis dui sit amet urna volutpat, ac rutrum magna volutpat. Sed gravida tincidunt laoreet. Nulla nec enim vitae nulla vehicula tempus.

Related news

Multimedia October 18, 2023
The Process of CDMO Selection for Antibody Development: Matching Capabilities to Need
In this webinar, you'll learn how to identify key solution features, define patient experience expectations, generate evidence, and more!
Publications September 21, 2023
Essential Elements of Technology Transfer
Peter Alexander, Senior Consultant, CMC, co-authored an article about technology transfer categories, essential elements, and documentation.
Publications September 19, 2023
Opportunities and Challenges in the Therapeutic and CDMO Markets
Our Transaction Advisory experts have analyzed the CDMO industry trends, M&A activities, and projected growth in this CHEManager article.
CDMO Pharma
Publications September 12, 2023
Global MedTech CDMO M&A Update
Discover key market insights, deal activities and their implications, and factors driving the growth and evolution of the global CDMO market.
Blog July 13, 2023
2023 Biologics & Advanced Therapies Contract Manufacturing Report: Executive Summary
Get in-depth market analysis, detailed examination of transactional activity, and insight into development of Biologics and ATs CDMO services.
Biologics Biotech CDMO
Publications July 13, 2023
2023 Biologics & Advanced Therapies Contract Manufacturing Report
Get the latest Biologics & Advanced Therapies (ATs) Contract Manufacturing insights in this report on current trends in the industry.
Biologics CDMO
News July 10, 2023
2023 Biologics and Advanced Therapies Contract Manufacturing Report is Launched
Alira Health, a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, announced today the publication of the 2023 Biologics and Advanced(...)
Advanced Therapies Biologics CDMO Press Release
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.